Antares, Medac deal

Medac’s Medac Pharma subsidiary and Antares granted royalty-free cross-licenses for the U.S. manufacture and sale of Medac’s Rasuvo methotrexate and Antares’ Otrexup methotrexate to settle a 2014 s...